Zebra Capital Management LLC - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 274 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.00 and the average weighting 0.1%.

Quarter-by-quarter ownership
Zebra Capital Management LLC ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2020$438,000
+7.1%
18,446
-18.9%
0.63%
-4.4%
Q1 2020$409,000
-31.5%
22,742
-9.6%
0.66%
+24.7%
Q4 2019$597,000
+60.1%
25,163
+85.0%
0.53%
+29.9%
Q3 2019$373,000
+19.9%
13,604
+44.8%
0.41%
+153.4%
Q2 2019$311,0009,3980.16%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
ASHFORD CAPITAL MANAGEMENT INC 698,676$41,816,0005.51%
Provident Investment Management, Inc. 543,194$32,510,0004.61%
NEUMEIER POMA INVESTMENT COUNSEL LLC 426,250$25,511,0002.37%
KOPP INVESTMENT ADVISORS LLC 41,879$2,506,0002.35%
AlphaOne Investment Services, LLC 126,279$7,558,0002.17%
Ranger Investment Management 468,933$28,066,0001.96%
Bruce & Co., Inc. 158,058$9,459,0001.88%
Penserra Capital Management LLC 244,371$29,030,0001.83%
SHAKER INVESTMENTS LLC/OH 49,642$2,971,0001.83%
Bridge City Capital, LLC 47,795$2,861,0001.81%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders